The writers reported the increased sensitivity to pain following morphine is due to the activation of an immune system receptor, TLR4, designed to detect harmful bacteria.
The study also found when morphine is metabolized in a patient’s body, one metabolite, M6G, can enter the nervous system and relieve pain, but another metabolite, M3G, has no pain-relieving role.
One of the findings was if morphine could be administered along with a molecule to inhibit TLR4, then the unwanted pain could be reduced.
More Articles on Anesthesia:
OIG: Anesthesia Arrangements With ASCs Could Lead to Trouble
Colorado Appeals Court Rules CRNAs Can Administer Anesthesia Without Supervision
Anesthesia Medical Group Venture Raises $42M
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
